Nantahala Capital Management »

Dianthus Therapeutics shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.4M 328k 10.40
2023-09-30 $4.6M 337k 13.67

More positions owned by Nantahala Capital Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Russell 2000 Etf (IWM)
Soleno Therapeutics (SLNO)
Soleno Therapeutics (SLNO)
Establishment Labs Holdings Ord (ESTA)
Establishment Labs Holdings Ord (ESTA)
Meta Financial (CASH)
Meta Financial (CASH)
Costco Wholesale Corporation Put Option (COST)
Costco Wholesale Corporation Put Option (COST)
Imax Corp Cad (IMAX)
Imax Corp Cad (IMAX)
Hilton Grand Vacations (HGV)

View all positions for Nantahala Capital Management

Top funds holding Dianthus Therapeutics

Fairmount Funds Management
5AM Venture Management
Avidity Partners Management
VR Adviser
Octagon Capital Advisors
Tang Capital Management
Nantahala Capital Management
Atlas Venture Life Science Advisors
Alphabet
Vanguard Group
Fred Alger Management
Millennium Management
Laurion Capital Management
Hussman Econometrics Advisors
Arrowpoint Asset Management

View all funds holding Dianthus Therapeutics